Skip to main content
. 2022 Sep 26;2022:8691842. doi: 10.1155/2022/8691842

Table 2.

Study lesions and index procedure characteristics and in-stent velocities at follow-up.

DM (n = 45) Non-DM (n = 61) p value
RICA (n, %) 25 (55.6) 32 (52.5) 0.75
Both sides (n, %) 4 (8.9) 1 (1.6) 0.08
Diameter stenosis; QCA (%) 84.1 ± 0.09 82.2 ± 0.10 0.34
Lesion length (mm) 18.7 ± 6.28 20.4 ± 5.60 0.15
Plaque type
 Type 1 (%) 12 (26.7) 6 (9.8) 0.02
 Type 2 (%) 16 (35.6) 17 (27.9) 0.40
 Type 3 (%) 4 (8.9) 16 (26.2) 0.02
 Type 4 (%) 4 (8.9) 14 (22.9) 0.06
 Type 5 (%) 9 (20.0) 8 (13.1) 0.34
 Type 1+2 (%) 28 (62.2) 23 (37.7) 0.01
 Type 1+2+5 (%) 37 (82.2) 31 (50.8) <0.001
Baseline PSV (m/s) 3.64 ± 1.06 3.75 ± 1.3 0.65
Baseline EDV (m/s) 1.21 ± 0.59 1.28 ± 0.72 0.58
Proximal EPD (n, %) 27 (60) 22 (36.1) 0.014
Distal EPD (n, %) 18 (40) 39 (63.9)
Direct stenting (n, %) 3 (6.7) 6 (9.8) 0.56
Max. postdilatation pressure (mean ± SD; atm) 20.22 ± 3.44 19.31 ± 4.44 0.18
Postdilatation balloon catheter diameter (mean ± SD; mm) 5.12 ± 0.34 5.24 ± 0.34 0.09
Residual diameter stenosis; QCA (%) 6.1 ± 0.08 5.9 ± 0.05 0.84
Stent diameter (mean ± SD; mm) 8.13 ± 0.73 8.21 ± 0.69 0.57
Stent length (mean ± SD; mm) 32.22 ± 4.2 33.61 ± 7.97 0.25
Vascular closure device use (n, %) 24 (53) 35 (57) 0.68
30-day follow-up
PSV (m/s ± SD) 0.73 ± 0.34 0.64 ± 0.24 0.17
EDV (m/s ± SD) 0.18 ± 0.08 0.17 ± 0.07 0.60
12-month follow-up
PSV (m/s ± SD) 0.87 ± 0.59 0.78 ± 0.31 0.37
EDV (m/s ± SD) 0.22 ± 0.18 0.21 ± 0.09 0.74

RICA: right internal carotid artery; QCA: quantitative comparative analysis; PSV: peak systolic velocity; EDV: end diastolic velocity; EPD: embolic protection device. Note that continuous variables presented as mean ± SD; DUS plaque type according to Gray-Weale classification (type 1: uniformly unechoic or hypoechoic; type 2: predominantly (>50%) hypoechoic; type 3: predominantly (>50%) hyperechoic; type 4: uniformly hyperechoic; type 5: uniformly echogenic with posterior shadowing (calcified plaque)) [14].